2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation Public Deposited

Downloadable Content

Download PDF
  • Rahko, Peter S.
  • Casey, Donald E.
  • Tarkington, Lynn G.
  • Michl, Keith
  • Mancini, Donna M.
  • Krumholz, Harlan M.
  • Ganiats, Theodore G.
  • Page, Richard L.
  • Konstam, Marvin A.
  • Ettinger, Steven M.
  • Kushner, Frederick G.
  • Chin, Marshall H.
  • Jacobs, Alice K.
  • Smith, Sidney C., Jr.
    • Affiliation: School of Medicine, Division of Cardiology, Department of Medicine
  • Yancy, Clyde W.
  • Nishimura, Rick A.
  • Silver, Marc A.
  • Creager, Mark A.
  • Jessup, Mariell
  • Buller, Christopher E.
  • Francis, Gary S.
  • Oates, John A.
  • Stevenson, Lynne Warner 
  • Abraham, William T.
  • Feldman, Arthur M.
  • Hunt, Sharon Ann
  • Lytle, Bruce W.
  • Heart failure (HF) is a major and growing public health problem in the United States. Approximately 5 million patients in this country have HF, and over 550,000 patients are diagnosed with HF for the first time each year. The disorder is the primary reason for 12 to 15 million office visits and 6.5 million hospital days each year. From 1990 to 1999, the annual number of hospitalizations has increased from approximately 810,000 to over 1 million for HF as a primary diagnosis and from 2.4 to 3.6 million for HF as a primary or secondary diagnosis. In 2001, nearly 53 000 patients died of HF as a primary cause. The number of HF deaths has increased steadily despite advances in treatment, in part because of increasing numbers of patients with HF due to better treatment and “salvage” of patients with acute myocardial infarctions (MIs) earlier in life. Heart failure is primarily a condition of the elderly, and thus the widely recognized “aging of the population” also contributes to the increasing incidence of HF. The incidence of HF approaches 10 per 1000 population after age 65, and approximately 80% of patients hospitalized with HF are more than 65 years old. Heart failure is the most common Medicare diagnosis-related group (i.e., hospital discharge diagnosis), and more Medicare dollars are spent for the diagnosis and treatment of HF than for any other diagnosis. The total estimated direct and indirect costs for HF in 2005 were approximately $27.9 billion. In the United States, approximately $2.9 billion annually is spent on drugs for the treatment of HF.
Date of publication
  • doi:10.1161/CIRCULATIONAHA.109.192065
  • 2-s2.0-65549145093
Related resource URL
Resource type
  • Journal Item
Rights statement
  • In Copyright
Journal title
  • Circulation
Journal volume
  • 119
Journal issue
  • 14
Page start
  • e391
Page end
  • e479
  • English
  • Postprint
  • ‎0009-7322

This work has no parents.